Utilization of Ayurveda in health care: An approach for prevention, health promotion, and treatment of disease. Part 1 - Ayurveda, the science of life

Journal of Alternative and Complementary Medicine

Volumn 13, Issue 9, 2007, Pages 1011-1019

  Sharma, Hari ^a,b   Chandola, H M ^c   Singh, Gurdip ^c   Basisht, Gopal ^d,e  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GUJARAT AYURVED UNIVERSITY   (India)

^d ORLANDO REGIONAL MEDICAL CENTER   (United States)

^e Full Circle Community Development ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AYURVEDIC DRUG; INTERLEUKIN 2; TOXIN;

ALLOPATHY; ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ANXIETY; AYURVEDA; CHRONIC DISEASE; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG PURIFICATION; EXERCISE; FOLLOW UP; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HEALTH STATUS; HERBAL MEDICINE; HUMAN; HYPERTENSION; HYPERTHERMIC THERAPY; INDIA; LIFESTYLE; LONGEVITY; MEDITATION; PARKINSON DISEASE; PREVENTION STUDY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; REJUVENATION; REVIEW; SLEEP DISORDER; SPICE;

ANTIOXIDANTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HOLISTIC HEALTH; HUMANS; INDIA; LIFE STYLE; MEDICINE, AYURVEDIC; MEDITATION; PHYTOTHERAPY; PLANT EXTRACTS; RESEARCH DESIGN; SPICES;

EID: 36749040805     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2007.7017-A     Document Type: Review

References (118)

1. World Health Organization. CVD Prevention and Control: Missed opportunities. Online document at: www.who.int/cardiovascular_diseases/ prevention_control/en/ Accessed August 28, 2007.
2. Stewart BW, Kleihues P, eds. World Cancer Report. Lyon, France: IARC Press, International Agency for Research on Cancer, 2003.
3. World Health Organization. Diabetes Programme. Online document at: www.who.int/diabetes/facts/world_figures/en/ Accessed August 28, 2007.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998;279:1200-1205.
5. Morrissey J. Patient safety proves elusive. Five years after publication of the IOM's "To Err is Human," there's plenty of activity on patient safety, but progress is another matter. Modern Healthcare 2004;34:6-7, 24-25, 28-32.
6. Starfield B. Is US health really the best in the world? JAMA 2000;284:483-485.
7. Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med 1981;304:638-642.
8. Chowka P. Major US and UK studies heighten concerns about conventional medical care. Online document at: www.naturalhealthline.com Accessed March 17, 2001.
9. Hoffman C, Rice D, Sung H-Y. Persons with chronic conditions: Their prevalence and costs. JAMA 1996;276:1473-1479.
10. Bodeker G, Ong C-K, Grundy C, et al., eds. WHO Global Atlas of Traditional, Complementary and Alternative Medicine: Text and Map Volumes. Kobe, Japan: World Health Organization, The WHO Centre for Health Development, 2005.
11. Lavekar GS, Sharma SK. Republic of India. WHO South-East Asia Region: Regional overview and selected country chapters. In: Bodeker G, Ong C-K, Grundy C, et al., eds. WHO Global Atlas of Traditional, Complementary and Alternative Medicine: Text and Map Volumes. Kobe, Japan: World Health Organization, The WHO Centre for Health Development, 2005:89-96.
12. Valiathan MS. Towards Ayurvedic Biology. A Decadal Vision Document. Bangalore, India: Indian Academy of Sciences, 2006.
13. Mishra LC, ed. Scientific Basis for Ayurvedic Therapies. New York: CRC Press, 2004.
14. Mashelkar RA. India's R&D: Reaching for the top. Science 2005;307:1415-1417.
15. Patwardhan B. Traditional Medicine: Modern Approach for Affordable Global Health. Geneva: World Health Organization, 2005.
16. Valiathan MS. The Legacy of Caraka. New Delhi, India: Orient Longman, 2003.
17. Valiathan MS. The Legacy of Susruta. New Delhi, India: Orient Longman, 2007.
18. Upaohyaya VY, ed. Ashtanga Hridayam. Varanasi, India: Chaukambha Sanskrit Sansthan, 1982.
19. Sharma H, Clark C. Contemporary Ayurveda. London: Churchill Livingstone, 1998.
20. Puri HS. Rasayana: Ayurvedic Herbs for Longevity and Rejuvenation. London: Taylor and Francis, 2003.
21. Govindarajan R, Vijayakumar M, Pushpangadan P. Antioxidant approach to disease management and the role of "Rasayana" herbs of Ayurveda. J Ethnopharmacol 2005;99:165-178.
22. Micklefield GH, Greving I, May B. Effects of peppermint oil and caraway oil on gastroduodenal motility. Phytother Res 2000;14:20-23.
23. May B, Köhler S, Schneider B. Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther 2000;14:1671-1677.
24. Pers M, Pers B. A crossover comparative study with two bulk laxatives. J Int Med Res 1983;11:51-53.
25. Tomás-Ridocci M, Anón R, Mínguez M, et al. The efficacy of Plantago ovata as a regulator of intestinal transit. A double-blind study compared to placebo. [in Spanish] Rev Esp Enferm Dig 1992;82:17-22.
26. Shanmugasundaram ER, Rajeswari G, Baskaran K, et al. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol 1990;30:281-294.
27. Chaudhury RR. Antidiabetic effect of Vijayasar (Pterocarpus marsupium). In: Gupta SK, ed. Pharmacology and Therapeutics in the New Millennium. New Delhi, India: Narosa Publishing House, 2001:355-356
28. Sharma RD, Sarkar A, Hazra DK, et al. Hypolipidaemic effect of fenugreek seeds: A chronic study in non-insulin dependent diabetic patients. Phytother Res 1996;10:332-334.
29. Waheed A, Miana GA, Ahmad SI. Clinical investigation of hypoglycemic effect of seeds of Azadirachta indica in type-2 (NIDDM) diabetes mellitus. Pak J Pharm Sci 2006;19:322-325.
30. Khan A, Safdar M, Ali Khan MM, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215-3218.
31. Sircar AR, Ahuja RC, Natu SM, et al. Hypoglycemic, hypolipidemic and general beneficial effects of an herbal mixture MA-471. Altern Ther Clin Pract 1996;3:26-31.
32. Chopra A, Lavin P, Patwardhan B, Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 2004;10:236-245.
33. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: A double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991;33:91-95.
34. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: A randomized double blind placebo controlled trial. Phytomedicine 2003;10:3-7.
35. Singh BB, Mishra LC, Vinjamury SP, et al. The effectiveness of Commiphora mukul for osteoarthritis of the knee: An outcomes study. Altern Ther Health Med 2003;9:74-79.
36. Sumantran VN, Kulkarni A, Boddul S, et al. Chondroprotective potential of root extracts of Withania somnifera in osteoarthritis. J Biosci 2007;32:299-307.
37. Khanna D, Sethi G, Ahn KS, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 2007;7:344-351.
38. Xin-Hua W, Chang-Qing L, Xing-Bo G, Lin-Chun F. A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B. Southeast Asian J Trop Med Public Health 2001;32:140-142.
39. Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: In vitro and in vivo studies. Proc Natl Acad Sci USA 1987;84:274-278.
40. Hankey A. Ayurvedic physiology and etiology: Ayurvedo Amritanaam. The doshas and their functioning in terms of contemporary biology and physical chemistry. J Altern Complement Med 2001;7:567-574.
41. Hankey A. A test of the systems analysis underlying the scientific theory of Ayurveda's tridosha. J Altern Complement Med 2005;11:385-390.
42. Joshi RR. A biostatistical approach to Ayurveda: Quantifying the tridosha. J Altern Complement Med 2004;10:879-889.
43. Patwardhan B, Joshi K, Chopra A. Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda. J Altern Complement Med 2005;11:349-353.
44. Sharma H, Mishra RK, with Meade JG. The Answer to Cancer. New York: SelectBooks, 2002.
45. Stapp HP. Mind, Matter and Quantum Mechanics. New York: Springer-Verlag, 1994.
46. Arias AJ, Steinberg K, Banga A, Trestman RL. Systematic review of the efficacy of meditation techniques as treatments for medical illness. J Altern Complement Med 2006;12:817-832.
47. Lutz A, Greischar LL, Rawlings NB, et al. Long-term meditators self-induce high-amplitude gamma synchrony during mental practice. Proc Natl Acad Sci USA 2004;101:16369-16373.
48. Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. NeuroReport 2005;16):1893-1897.
49. Wallace RK. Physiological effects of Transcendental Meditation. Science 1970;167:1751-1754.
50. Jevning JR, Wilson AF, Davison JM. Adrenocortical activity during meditation. Horm Behav 1978;10:54-60.
51. Glaser J, Brind J, Vogelman J, et al. Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs. J Behav Med 1992;15:327-341.
52. Wallace RK, Dillbeck MC, Jacobe E, Harrington B. The effects of the Transcendental Meditation and TM-Sidhi program on the aging process. Int J Neurosci 1982;16:53-58.
53. Castillo-Richmond A, Schneider RH, Alexander CN, et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke 2000;31:568-573.
54. Orme-Johnson DW. Medical care utilization and the Transcendental Meditation program. Psychosom Med 1987;49:493-507.
55. Barnes VA, Orme-Johnson DW. Clinical and pre-clinical applications of the Transcendental Meditation Program in the prevention and treatment of essential hypertension and cardiovascular disease in youth and adults. Curr Hypertens Rev 2006;2:207-218.
56. Herron RE, Hillis SL. The impact of the Transcendental Meditation program on government payments to physicians in Quebec: An update. Am J Health Promot 2000;14:284-291.
57. Chan D, Woollacott M. Effects of level of meditation experience on attentional focus: Is the efficiency of executive or orientation networks improved? J Altern Complement Med 2007;13:651-657.
58. Sharma HM. Free radicals and natural antioxidants in health and disease. J Appl Nutr 2002;52:26-44.
59. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003;23:363-398.
60. Kawamori T, Lubet R, Steele VE, et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999;59:597-601.
61. Limtrakul P, Anuchapreeda S, Lipigorngoson S, Dunn FW. Inhibition of carcinogen induced c-Ha-ras and c-fos protooncogenes expression by dietary curcumin. BMC Cancer 2001;1:1.
62. Piper JT, Singhal SS, Salameh MS, et al. Mechanisms of anticarcinogenic properties of curcumin: The effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 1998;30:445-456.
63. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. Adv Exp Med Biol 2007;595:1-75.
64. Shishodia S, Sethi G, Aggarwal BB. Curcumin: Getting back to the roots. Ann NY Acad Sci 2005;1056:206-217.
65. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med 2003;9:161-168.
66. Deshpande UR, Gadre SG, Raste AS, et al. Protective effect of turmeric (Curcuma longa L.) extract on carbon tetrachloride-induced liver damage in rats. Indian J Exp Biol 1998;36:573-577.
67. Mahady GB, Pendland SL, Yun G, Lu ZZ. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res 2002;22:4179-4181.
68. Apisariyakul A, Vanittanakom N, Buddhasukh D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 1995;49:163-169.
69. Sidhu GS, Singh AK, Thaloor D, et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen 1998;6:167-177.
70. Babu PS, Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997;166:169-175.
71. Olajide OA. Investigation of the effects of selected medicinal plants on experimental thrombosis. Phytother Res 1999;13:231-232.
72. Quiles JL, Mesa MD, Ramirez-Tortosa CL, et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 2002;22:1225-1231.
73. Kim DSHL, Park S-Y, Kim J-Y. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA(1-42) insult. Neurosci Lett 2001;303:57-61.
74. Park S-Y, Kim DSHL. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease. J Nat Prod 2002;65:1227-1231.
75. Ringman JM, Frautschy SA, Cole GM, et al. A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2005;2:131-136.
76. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005;280:5892-5901.
77. Chithra V, Leelamma S. Coriandrum sativum changes the levels of lipid peroxides and activity of antioxidant enzymes in experimental animals. Indian J Biochem Biophys 1999;36:59-61.
78. Chithra V, Leelamma S. Hypolipidemic effect of coriander seeds (Coriandrum sativum): Mechanism of action. Plant Foods Hum Nutr 1997;51:167-172.
79. Gray AM, Flatt PR. Insulin-releasing and insulin-like activity of the traditional anti-diabetic plant Coriandrum sativum (coriander). Br J Nutr 1999;81:203-209.
80. Delaquis PJ, Stanich K, Girard B, Mazza G. Antimicrobial activity of individual and mixed fractions of dill, cilantro, coriander and eucalyptus essential oils. Int J Food Microbiol 2002;74:101-109.
81. Dhandapani S, Subramanian VR, Rajagopal S, Namasivayam N. Hypolipidemic effect of Cuminum cyminum L. on alloxan-induced diabetic rats. Pharmacol Res 2002;46:251-255.
82. Singh G, Kapoor IPS, Pandey SK, et al. Studies on essential oils: Part 10; Antibacterial activity of volatile oils of some spices. Phytother Res 2002;16:680-682.
83. Sambaiah K, Srinivasan K. Influence of spices and spice principles on hepatic mixed function oxygenase system in rats. Indian J Biochem Biophys 1989;26:254-258.
84. Kumar N, Kumar A. A comparison of different drug schedules under different groups of Grahani Roga. J Res Ayurveda Siddha 1997;18:79.
85. Liu N, Huo G, Zhang L, Zhang X. Effect of Zingiber officinale Rosc on lipid peroxidation in hyperlipidemia rats. [in Chinese]. Wei Sheng Yan Jiu 2003;32:22-23.
86. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999;428:305-327.
87. Penna SC, Medeiros MV, Aimbire FSC, et al. Anti-inflammatory effect of the hydralcoholic extract of Zingiber officinale rhizomes on rat paw and skin edema. Phytomedicine 2003;10:381-385.
88. Ficker CE, Arnason JT, Vindas PS, et al. Inhibition of human pathogenic fungi by ethnobotanically selected plant extracts. Mycoses 2003;46:29-37.
89. Vishwakarma SL, Pal SC, Kasture VS, Kasture SB. Anxiolytic and antiemetic activity of Zingiber officinale. Phytother Res 2002;16:621-626.
90. Kim DSHL, Kim J-Y, Han YS. Alzheimer's disease drug discovery from herbs: Neuroprotectivity from β-amyloid(1-42) insult. J Altern Complement Med 2007;13:333-340.
91. Kim DSHL, Kim D-S, Oppel MN. Shogaols from Zingiber officinale protect IMR32 human neuroblastoma and normal human umbilical vein endothelial cells from β-amyloid(25-35) insult. Planta Med 2002;68:375-376.
92. Koscielny J, Klüßendorf D, Latza R, et al. The antiatherosclerotic effect of Allium sativum. Atherosclerosis 1999;144:237-249.
93. Bordia A, Verma SK, Srivastava KC. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1998;58:257-263.
94. Al-Qattan KK, Alnaqeeb MA, Ali M. The antihypertensive effect of garlic (Allium sativum) in the rat two-kidney - one-clip Goldblatt model. J Ethnopharmacol 1999;66:217-222.
95. Thomson M, Ali M. Garlic [Allium sativum]: A review of its potential use as an anti-cancer agent. Curr Cancer Drug Targets 2003;3:67-81.
96. Colic M, Vucevic D, Kilibarda V, et al. Modulatory effects of garlic extracts on proliferation of T-lymphocytes in vitro stimulated with concanavalin A. Phytomedicine 2002;9:117-124.
97. Hodge G, Hodge S, Han P. Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: Potential therapeutic use in the treatment of inflammatory bowel disease. Cytometry 2002;48:209-215.
98. Dikasso D, Lemma H, Urga K, et al. Investigation on the antibacterial properties of garlic (Allium sativum) on pneumonia causing bacteria. Ethiop Med J 2002;40:241-249.
99. Tahiliani P, Kar A. Mitigation of thyroxine-induced hyperglycaemia by two plant extracts. Phytother Res 2003;17:294-296.
100. Chauhan NB, Sandoval J. Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice. Phytother Res 2007;21:629-640.
101. Mang B, Wolters M, Schmitt B, et al. Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 2006;36:340-344.
102. Hlebowicz J, Darwiche G, Björgell O, Almér L. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr 2007;85:1552-1556.
103. Babu PS, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde: A potential antidiabetic agent. Phytomedicine 2007;14:15-22.
104. Mancini-Filho J, Van-Koiij A, Mancini DA, et al. Antioxidant activity of cinnamon (Cinnamomum zeylanicum, Breyne) extracts. Boll Chim Farm 1998;137:443-447.
105. Shan B, Cai YZ, Sun M, Corke H. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem 2005;53:7749-7759.
106. López P, Sánchez C, Batlle R, Nerín C. Solid- and vaporphase antimicrobial activities of six essential oils: Susceptibility of selected foodborne bacterial and fungal strains. J Agric Food Chem 2005;53:6939-6946.
107. Kamath JV, Rana AC, Chowdhury AR. Pro-healing effect of Cinnamomum zeylanicum bark. Phytother Res 2003;17:970-972.
108. Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci 2004;86:789-799.
109. Sharma HM. Phytochemical synergism: Beyond the active ingredient model. Altern Ther Clin Pract 1997;4:91-96.
110. Subapriya R, Nagini S. Medicinal properties of neem leaves: A review. Curr Med Chem Anticancer Agents 2005;5:149-156.
111. Brahmachari G. Neem: An omnipotent plant. A retrospection. Chembiochem 2004;5:408-421.
112. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of Neem (Azadirachta indica). Curr Sci 2002;82:1336-1345.
113. Bandyopadhyay U, Biswas K, Sengupta A, et al. Clinical studies on the effect of Neem (Azadirachta indica) bark extract on gastric secretion and gastroduodenal ulcer. Life Sci 2004;75:2867-2878.
114. Sharma HM. Maharishi Ayurveda. In: Micozzi MS, ed. Fundamentals of Complementary and Integrative Medicine, 3rd ed. St. Louis: Saunders Elsevier, 2006:518-535.
115. Joshi S. Panchakarma: Detoxification and rejuvenation therapy. Light Ayurveda J 2004;III:10-11.
116. Dick M. Ayurvedic treatment and the role of Panchakarma. Light Ayurveda J 2004;III:12-13.
117. Sharma HM, Nidich SI, Sands D, Smith DE. Improvement in cardiovascular risk factors through Panchakarma purification procedures. J Res Educ Indian Med 1993;12:2-13.
118. Herron RE, Fagan JB. Lipophil-mediated reduction of toxicants in humans: An evaluation of an Ayurvedic detoxification procedure. Altern Ther Health Med 2002;8:40-51.